The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib
- Type
- Retraction
- Notice date
- 3/7/2022 0:00
- Journal
- Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
- Publisher
- International Scientific Information, Inc
- Notice DOI
- 10.12659/msm.936571
- Original paper DOI
- 10.12659/msm.910084